National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Treatment (PDQ®)     
Last Modified: 08/22/2007
Health Professional Version
Changes to This Summary (08/22/2007)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Classification of Pediatric Myeloid Malignancies 1

Added Meshinchi et al. as reference 52 2.

Added Chou et al. as reference 74 2.

Added Thiede et al. as reference 75 2.

Added text 2 stating that immunohistochemical methods can be used to accurately identify patients with nucleophosmin mutations.

Added Falini et al. as reference 77 2.

Treatment Overview for Acute Myeloid Leukemia 3

Added text 4 stating that the Berlin-Frankfurt-Munster 98 study confirmed a lack of benefit for the use of granulocyte colony-stimulating factor (cited Lehrnbecher et al. as reference 9).

Treatment of Newly Diagnosed Acute Myeloid Leukemia 5

Added Creutzig et al. as reference 13 6.

Postremission Therapy for Acute Myeloid Leukemia 7

Added text 8 stating that indications for autologous and allogenic hematopoietic stem cell transplantation have been published (cited Oliansky et al. as reference 6).



Table of Links

1http://cancer.gov/cancertopics/pdq/treatment/childAML/HealthProfessional/9.cdr#
Section_9
2http://cancer.gov/cancertopics/pdq/treatment/childAML/HealthProfessional/138.cd
r#Section_138
3http://cancer.gov/cancertopics/pdq/treatment/childAML/HealthProfessional/46.cdr
#Section_46
4http://cancer.gov/cancertopics/pdq/treatment/childAML/HealthProfessional/49.cdr
#Section_49
5http://cancer.gov/cancertopics/pdq/treatment/childAML/HealthProfessional/52.cdr
#Section_52
6http://cancer.gov/cancertopics/pdq/treatment/childAML/HealthProfessional/59.cdr
#Section_59
7http://cancer.gov/cancertopics/pdq/treatment/childAML/HealthProfessional/176.cd
r#Section_176
8http://cancer.gov/cancertopics/pdq/treatment/childAML/HealthProfessional/178.cd
r#Section_178